In 2024, Ryman Healthcare completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).
Ryman Healthcare has also provided a category-level breakdown for 2 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Market-Based | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Location-Based | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
In 2024, the total operational greenhouse gas (GHG) emissions of Ryman Healthcare amounted to 13,941 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2021, the total operational greenhouse gas (GHG) emissions of Ryman Healthcare increased by 13.18%, suggesting that the company faced challenges in reducing its emissions from its core operations.
In 2024, the total Scope 1 emissions of Ryman Healthcare were 4,318 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Compared to the previous year (2021), Ryman Healthcare's Scope 1 emissions remained relatively stable, indicating that Ryman Healthcare's emissions have plateaued with no significant change in its operational footprint.
In 2024, Ryman Healthcare reported Scope 2 greenhouse gas (GHG) emissions of 8,234 tCOâ‚‚e using the market-based method, and 9,623 tCOâ‚‚e using the location-based method.
Compared to the previous year (2021), Ryman Healthcare's Scope 2 emissions (Location-Based) rose by 20.27% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy
In 2024, Ryman Healthcare reported its Scope 2 emissions using the market-based method and using the location-based method.
In 2024, Ryman Healthcare reported 4,123 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2024 disclosure of Ryman Healthcare includes a breakdown across 2 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2021, demonstrating consistent Scope 3 emissions reporting coverage year over year.
In 2024, Ryman Healthcare reported total Scope 3 emissions of 4,123 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment.
Compared to the previous year (2021), Ryman Healthcare's Scope 3 emissions increased by 14.53%, suggesting that the company faced challenges in reducing emissions across its value chain.
In 2024, Ryman Healthcare reported emissions for 2 out of the 15 Scope 3 categories defined by the GHG Protocol.
The limited disclosure restricts visibility into specific emission sources across the company's value chain.
In 2024, the largest contributors to Ryman Healthcare's Scope 3 emissions were:
In 2024, Ryman Healthcare reported a total carbon footprint of 18,064 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 13.48% increase compared to 2021, suggesting a rise in emissions across its operations or value chain.
The largest contributor to Ryman Healthcare's total carbon footprint was Scope 2 emissions, accounting for 53.27% of the company's total carbon footprint, followed by Scope 1 emissions at 23.9%.